Cargando...
Tolerogenic Nanoparticles to Treat Islet Autoimmunity
PURPOSE OF REVIEW: The current standard therapy for type 1 diabetes (T1D) is insulin replacement. Autoimmune diseases are typically treated with broad immunosuppression, but this has multiple disadvantages. Induction of antigen-specific tolerance is preferable. The application of nanomedicine to the...
Gardado en:
| Publicado en: | Curr Diab Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5748287/ https://ncbi.nlm.nih.gov/pubmed/28791576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11892-017-0914-z |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|